Zelira Therapeutics Limited
ZLDAF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $38 | $586 | $65 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $198 | $198 | $680 |
| Inventory | $478 | $1,333 | $1,252 | $1,397 |
| Other Curr. Assets | $28 | $0 | $2,114 | $0 |
| Total Curr. Assets | $614 | $1,569 | $4,260 | $2,142 |
| Property Plant & Equip (Net) | $122 | $191 | $225 | $313 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $521 | $580 | $655 | $733 |
| Long-Term Investments | $0 | $0 | $43 | $42 |
| Tax Assets | $0 | $0 | $0 | -$42 |
| Other NC Assets | $44 | $46 | $0 | $42 |
| Total NC Assets | $686 | $816 | $923 | $1,088 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,301 | $2,385 | $5,183 | $3,229 |
| Liabilities | – | – | – | – |
| Payables | $3,450 | $4,061 | $3,407 | $2,376 |
| Short-Term Debt | $1,990 | $6,070 | $3,540 | $1,366 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $1,114 |
| Total Curr. Liab. | $5,591 | $10,280 | $7,093 | $5,004 |
| LT Debt | $0 | $0 | $2,114 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $84 | $2,263 | $212 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $151 | $233 | $296 | $212 |
| Total Liabilities | $5,591 | $10,364 | $9,357 | $5,216 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $45,520 | $45,516 | $45,516 | $45,516 |
| Retained Earnings | -$84,964 | -$83,747 | -$81,336 | -$78,902 |
| AOCI | $34,983 | $29,829 | $31,305 | $31,046 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$4,460 | -$8,402 | -$4,515 | -$2,341 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $170 | $423 | $342 | $354 |
| Total Liab. & Tot. Equity | $1,301 | $2,385 | $5,183 | $3,229 |
| Net Debt | $1,985 | $6,031 | $5,067 | $1,301 |